A Phase I/II Trial of Chemoembolization for Hepatocellular Carcinoma Using a Novel Intra-Arterial Drug-Eluting Bead
Author:
Publisher
Elsevier BV
Subject
Gastroenterology,Hepatology
Reference50 articles.
1. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study;Lee;J Clin Oncol,2002
2. Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma;O’Suilleabhain;Br J Surg,2003
3. Hepatocellular carcinoma: current management and future trends;Carr;Gastroenterology,2004
4. Embolization and chemoembolization therapy for neuroendocrine tumors;Venook;Curr Opin Oncol,1999
5. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature;Tellez;Cancer,1998
Cited by 260 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Microbubbles bound to drug-eluting beads enable ultrasound imaging and enhanced delivery of therapeutics;Scientific Reports;2024-09-09
2. Efficacy of CalliSpheres ® drug-loaded microspheres combined with doxorubicin in hepatocellular carcinoma;Scandinavian Journal of Gastroenterology;2024-08-18
3. Locoregional interventional therapy for hepatocellular carcinoma: radiologic and clinical factors predictive of untreatable progression and time to untreatable progression;Frontiers in Pharmacology;2024-07-23
4. Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model;Frontiers in Pharmacology;2024-01-25
5. Drug-eluting beads versus conventional transarterial chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis;Medicine;2023-08-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3